Pathway Diagram
flowchart TD
BMAL1["BMAL1<br/>Circadian Regulator"]
HIF1A["HIF1A<br/>Hypoxia-Inducible Factor"]
VEGF["VEGF<br/>Vascular Endothelial<br/>Growth Factor"]
Angiogenesis["Angiogenesis<br/>Blood Vessel Formation"]
bevacizumab["Bevacizumab<br/>Anti-VEGF Therapy"]
ALS["ALS<br/>Amyotrophic Lateral<br/>Sclerosis"]
MS["Multiple Sclerosis<br/>Demyelinating Disease"]
Alzheimer["Alzheimer's Disease<br/>Neurodegeneration"]
Dementia["Dementia<br/>Cognitive Decline"]
TBI["Traumatic Brain Injury<br/>Acute Injury"]
Neuropathy["Neuropathy<br/>Nerve Damage"]
Inflammation["Inflammation<br/>Immune Response"]
Cancer["Cancer<br/>Malignancy"]
BMAL1 -->|"regulates"| VEGF
HIF1A -->|"regulates"| VEGF
VEGF -->|"promotes"| Angiogenesis
bevacizumab -->|"inhibits"| VEGF
VEGF -->|"activates"| ALS
VEGF -->|"expressed in"| MS
VEGF -->|"associated with"| Alzheimer
VEGF -->|"associated with"| Dementia
VEGF -->|"protective against"| TBI
VEGF -->|"expressed in"| Neuropathy
VEGF -->|"associated with"| Inflammation
VEGF -->|"activates"| Cancer
Angiogenesis -->|"supports"| TBI
Inflammation -->|"contributes to"| ALS
Inflammation -->|"contributes to"| MS
style VEGF fill:#006494
style BMAL1 fill:#4a1a6b
style HIF1A fill:#4a1a6b
style bevacizumab fill:#1b5e20
style Angiogenesis fill:#1b5e20
style TBI fill:#1b5e20
style ALS fill:#ef5350
style MS fill:#ef5350
style Alzheimer fill:#ef5350
style Dementia fill:#ef5350
style Inflammation fill:#ef5350
style Cancer fill:#ef5350
style Neuropathy fill:#5d4400VEGF
| Gene Symbol | VEGFA |
| Common Names | VEGF, VEGF-A |
| Protein | [Vascular Endothelial Growth Factor A](/proteins/vegfa-protein) |
| Location | 6p21.1 |
| NCBI Gene ID | 7422 |
| UniProt | [P15692](https://www.uniprot.org/uniprot/P15692) |
| Aliases | VEGF, MVCD1, VPF |
| Associated Diseases | ALS, ALZHEIMER, ALZHEIMER'S, ALZHEIMER'S DISEASE, Aging |
| KG Connections | 834 edges |
Overview
Vascular endothelial growth factor (VEGF), primarily encoded by the VEGFA gene, is a signaling protein that stimulates the formation of blood vessels (angiogenesis) and is essential for both normal vascular development and pathological neovascularization.1The biology of VEGF and its receptorsOpen reference Beyond its vascular functions, VEGF has emerged as a critical neuroprotective factor with direct effects on neuronal survival, neurogenesis, and neuroinflammation.2VEGF in the nervous systemOpen reference
Structure and Expression
The VEGFA gene produces multiple splice isoforms, with VEGF-A165 being the predominant form in the brain. The protein exists as a disulfide-linked homodimer and signals through three tyrosine kinase receptors: VEGFR-1 (Flt-1), VEGFR-2 (KDR/Flk-1), and VEGFR-3 (Flt-4).3VEGF receptor signalling - in control of vascular functionOpen reference In the central nervous system, VEGF is expressed by:
-
Neurons under hypoxic stress
-
Astrocytes and microglia
-
Endothelial cells
-
Neural progenitor cells
VEGF expression is primarily regulated by hypoxia-inducible factor 1-alpha (HIF-1α), which activates transcription under low oxygen conditions.4Purification and characterization of hypoxia-inducible factor 1Open reference
Normal Function
VEGF serves multiple physiological functions:
-
Angiogenesis: Promotes endothelial cell proliferation, migration, and survival, forming new blood vessels from pre-existing ones.5Molecular mechanisms and clinical applications of angiogenesisOpen reference
-
Neuroprotection: Directly protects neurons from apoptosis, excitotoxicity, and oxidative stress through VEGFR-2 signaling.6VEGF rescues hippocampal neurons from glutamate toxicityOpen reference
-
Neurogenesis: Stimulates neural stem cell proliferation and differentiation in the hippocampus and subventricular zone.7VEGF stimulates neurogenesis in vitro and in vivoOpen reference
-
Vascular Permeability: Increases blood-brain barrier permeability, which can be either beneficial (drug delivery) or detrimental (edema).8Vascular permeability factor (VPF, VEGF) in tumor biologyOpen reference
-
Neuroinflammation Modulation: Can either promote or suppress inflammation depending on context and receptor engagement.9VEGF-mediated inflammation in neurodegenerationOpen reference
Role in Neurodegeneration
Alzheimer’s Disease
VEGF plays a complex role in Alzheimer’s disease. Reduced VEGF levels have been observed in AD brains, and VEGF polymorphisms are associated with increased AD risk.10VEGF gene polymorphisms and Alzheimer's diseaseOpen reference VEGF may protect against AD through:
-
Promoting clearance of amyloid-beta via enhanced cerebral blood flow
-
Reducing tau hyperphosphorylation
-
Supporting neuronal survival in affected regions
-
Enhancing neurogenesis in the hippocampus2VEGF in the nervous systemOpen reference0
Paradoxically, elevated VEGF has been reported in amyloid plaques, potentially reflecting a compensatory response or pathological angiogenesis.2VEGF in the nervous systemOpen reference1
Parkinson’s Disease
In Parkinson’s disease, VEGF is upregulated in the substantia nigra, likely in response to dopaminergic neuron loss and hypoxia.2VEGF in the nervous systemOpen reference2 VEGF administration in animal models:
-
Protects dopaminergic neurons from toxin-induced degeneration
-
Improves motor function
-
Reduces neuroinflammation2VEGF in the nervous systemOpen reference3
However, excessive VEGF may contribute to blood-brain barrier dysfunction in PD.2VEGF in the nervous systemOpen reference4
Amyotrophic Lateral Sclerosis
VEGF has been implicated as a modifier gene in ALS. VEGF polymorphisms and reduced CSF VEGF levels have been reported in ALS patients.2VEGF in the nervous systemOpen reference5 In SOD1 transgenic mice:
-
VEGF delivery extends survival
-
VEGFR-2 signaling protects motor neurons
-
Combined VEGF and IGF-1 treatment shows synergistic effects2VEGF in the nervous systemOpen reference6
Stroke and Vascular Dementia
VEGF is induced after cerebral ischemia and plays dual roles in stroke recovery:
-
Acute phase: Increases vascular permeability, potentially worsening edema
-
Chronic phase: Promotes angiogenesis, neurogenesis, and functional recovery2VEGF in the nervous systemOpen reference7
In vascular cognitive impairment, VEGF may help restore cerebral perfusion and support cognitive function.2VEGF in the nervous systemOpen reference8
Therapeutic Targeting
VEGF-Based Therapies
Several therapeutic strategies targeting VEGF are being explored:
-
Gene Therapy: AAV-mediated VEGF delivery showed neuroprotection in animal models of PD, ALS, and stroke.2VEGF in the nervous systemOpen reference9
-
Recombinant VEGF: Direct administration has shown promise in preclinical models of neurodegeneration.3VEGF receptor signalling - in control of vascular functionOpen reference0
-
VEGF Mimetics: Small peptides that activate VEGFR-2 without promoting angiogenesis may offer neuroprotection without vascular side effects.3VEGF receptor signalling - in control of vascular functionOpen reference1
-
Exercise-Induced VEGF: Physical activity increases brain VEGF, contributing to exercise-induced neurogenesis and cognitive benefits.3VEGF receptor signalling - in control of vascular functionOpen reference2
Clinical Considerations
-
BBB Penetration: VEGF has limited blood-brain barrier penetration, requiring direct CNS delivery or BBB-disrupting strategies
-
Angiogenesis Risk: Excessive VEGF may promote pathological angiogenesis and edema
-
Cancer Concerns: Long-term VEGF upregulation could theoretically increase tumor risk3VEGF receptor signalling - in control of vascular functionOpen reference3
Gene Variants and Risk
| Variant | rsID | Effect | Disease Association |
|---|---|---|---|
| -2578C/A | rs699947 | Altered expression | AD, PD |
| +936C/T | rs3025039 | Decreased VEGF levels | ALS |
| -634G/C | rs2010963 | Increased expression | Stroke recovery |
Interactions
VEGF interacts with multiple pathways relevant to neurodegeneration:
-
HIF-1α: Primary transcriptional activator of VEGF under hypoxia
-
PI3K/AKT: Downstream survival signaling through VEGFR-2
-
Notch: Crosstalk in angiogenesis and neurogenesis
-
BDNF: Synergistic effects on neuronal survival and plasticity
See Also
External Links
References
- The biology of VEGF and its receptors
- VEGF in the nervous system
- VEGF receptor signalling - in control of vascular function
- Purification and characterization of hypoxia-inducible factor 1
- Molecular mechanisms and clinical applications of angiogenesis
- VEGF rescues hippocampal neurons from glutamate toxicity
- VEGF stimulates neurogenesis in vitro and in vivo
- Vascular permeability factor (VPF, VEGF) in tumor biology
- VEGF-mediated inflammation in neurodegeneration
- VEGF gene polymorphisms and Alzheimer's disease
- VEGF promotes clearance of amyloid-beta
- The role of VEGF in Alzheimer's disease
- VEGF upregulation in Parkinson's disease
- Neuroprotective effects of VEGF in Parkinson's disease models
- Blood-brain barrier changes in Parkinson's disease
- VEGF is a modifier of amyotrophic lateral sclerosis in mice and humans
- Treatment of motoneuron degeneration by intracerebroventricular delivery of VEGF
- VEGF in stroke recovery
- VEGF in vascular dementia
- AAV-VEGF gene therapy for Parkinson's disease
- Recombinant VEGF for neuroprotection
- VEGF mimetics for neuroprotection
- Exercise enhances learning and hippocampal neurogenesis in aged mice
- VEGF-A and the induction of pathological angiogenesis
Sister wikis (recently updated · no domain on this page)
- Agent Recipe: AI-for-Biology Closed-Loop with Reviewer Handoffs and Eval Contracts
- Agent Recipe: AI-for-Biology Closed-Loop with Reviewer Handoffs and Eval Contracts
- test
- JGBO-I27: Top 10 GBO Questions for Prioritization
- JGBO-I27: Top 10 GBO Questions for Prioritization
- Design Brief: Beta-test Evaluation Protocol for SciDEX v2 Design Trajectories
- Andy — Showcase Findings (auto-curated)
- Kris — Showcase Findings (auto-curated)
Recent activity here
No recent events touching this page.